| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
VPREB3 |
VPREB3, UNQ355/PRO619: Pre-B lymphocyte protein 3 precursor |
0.255 |
Evidence |
|
| MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
CD72 |
CD72: B-cell differentiation antigen CD72 |
0.255 |
Evidence |
|
| COL5A1 |
IPI00303313 |
EFEMP1 |
EFEMP1, FBLN3, FBNL: EGF-containing fibulin-like extracellular matrix protein 1 |
0.255 |
Evidence |
|
| C4BPB |
C4BPB: C4b-binding protein beta chain precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
| GZMH |
GZMH, CGL2, CTSGL2: Granzyme H precursor |
SPON2 |
SPON2, DIL1, UNQ435/PRO866: Spondin-2 precursor |
0.255 |
Evidence |
|
| ITGAX |
ITGAX, CD11C: Integrin alpha-X precursor |
IGSF6 |
IGSF6, DORA: Immunoglobulin superfamily member 6 precursor. |
0.255 |
Evidence |
|
| ITGAX |
ITGAX, CD11C: Integrin alpha-X precursor |
LILRB2 |
IPI00303952 |
0.255 |
Evidence |
|
| ITGAX |
ITGAX, CD11C: Integrin alpha-X precursor |
PLXNC1 |
PLXNC1, VESPR: Plexin-C1 precursor |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
SEMA4D |
SEMA4D, CD100, SEMAJ: Semaphorin-4D precursor |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
SIGIRR |
SIGIRR, UNQ301/PRO342: Single Ig IL-1-related receptor |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
CD96 |
CD96: T-cell surface protein tactile precursor |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
ITGB7 |
ITGB7: Integrin beta-7 precursor |
0.255 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
MYD88 |
|
0.255 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
RNF130 |
RNF130: Goliath homolog precursor |
0.255 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
VPREB3 |
VPREB3, UNQ355/PRO619: Pre-B lymphocyte protein 3 precursor |
0.255 |
Evidence |
|
| CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
CD72 |
CD72: B-cell differentiation antigen CD72 |
0.255 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
E2F1 |
E2F1, RBBP3: Transcription factor E2F1 |
0.255 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CCNF |
CCNF: G2/mitotic-specific cyclin-F |
0.255 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
IGSF6 |
IGSF6, DORA: Immunoglobulin superfamily member 6 precursor. |
0.255 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
CD302 |
CD302, CLEC13A, DCL1, KIAA0022: CD302 antigen precursor |
0.255 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
CD93 |
CD93, C1QR1, MXRA4: Complement component C1q receptor precursor |
0.255 |
Evidence |
|
| CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
LILRA3 |
LILRA3, ILT6, LIR4: Leukocyte immunoglobulin-like receptor subfamily A member 3 |
0.255 |
Evidence |
|